Terms ending in 2037
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,125,134 | Kras G12C Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 10,633,381 | Kras G12C Inhibitors In force · High confidence | Array BioPharma Inc. | In force | High confidence | |
| US 10,647,715 | Kras G12C Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 10,689,377 | Kras G12C Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 11,267,812 | Kras G12C Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 11,214,571 | Process for the Preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and Salts Thereof In force · High confidence | Array BioPharma Inc. | In force | High confidence | |
| US 10,485,788 | Pharmaceutical Combinations In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 10,112,942 | Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors In force · Medium confidence | Array Biopharma Inc. | In force | Medium confidence | |
| US 10,137,124 | Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors In force · Medium confidence | Array Biopharma Inc. | In force | Medium confidence | |
| US 10,144,734 | Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| 7 more term ends in 2037 · Pro | |||||
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
16 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.